BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11113279)

  • 1. Inhibition of plasmin activity by sulfated polyvinylalcohol-acrylate copolymers.
    Vörös G; Kolev K; Csomor K; Machovich R
    Thromb Res; 2000 Nov; 100(4):353-61. PubMed ID: 11113279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.
    Henry BL; Abdel Aziz M; Zhou Q; Desai UR
    Thromb Haemost; 2010 Mar; 103(3):507-15. PubMed ID: 20024500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of heparin on plasmin and plasminogen activation].
    Manmi S
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen.
    Léránt I; Kolev K; Gombás J; Machovich R
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):311-20. PubMed ID: 10899632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
    Komorowicz E; Kolev K; Machovich R
    Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.
    Kumar Y; Vadivel K; Schmidt AE; Ogueli GI; Ponnuraj SM; Rannulu N; Loo JA; Bajaj MS; Bajaj SP
    Biochemistry; 2014 Jan; 53(3):505-17. PubMed ID: 24383758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5.
    Huet E; Cauchard JH; Berton A; Robinet A; Decarme M; Hornebeck W; Bellon G
    Biochem Pharmacol; 2004 Feb; 67(4):643-54. PubMed ID: 14757164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
    Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
    Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.
    Sidelmann J; Jespersen J; Kluft C; Gram J
    Clin Chim Acta; 1997 May; 261(1):43-56. PubMed ID: 9187504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
    Suenson E; Thorsen S
    Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK; Wolf B; Gonias SL
    Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.